ArticleACS pharmacology & translational science2023

Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor α Ratio.

Julian Laux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.